Tag: The VEINS 2023
Akura thrombectomy system for PE appears safe and demonstrates reduction of...
Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...
Six-month outcomes from phase-one trial of anti-inflammatory drug to assess benefit...
The open-label phase of the DEXTERITY-AFP trial investigating the Bullfrog microinfusion device—which involves the perivenous injection of the anti-inflammatory drug dexamethasone to improve patency...
One-year CLOUT data demonstrate low rate of PTS following treatment with...
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...